Lord, Abbett & Co
ACH

Lord, Abbett & Co’s Accendra Health ACH Stock Holding History

Lord, Abbett & Co’s Portfolio ACH Stock Details ACH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-169,000
Closed -$4.68M – 577
2024
Q1 		$4.68M Buy
+169,000
New +$3.75M 0.02% 480
2016
Q2 		– Sell
-84,000
Closed -$3.4M – 907
2016
Q1 		$3.4M Buy
+84,000
New +$3.13M 0.01% 773

Other funds holding ACH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Lord, Abbett & Co's ACH Position: Q2 2024 in Review

Lord, Abbett & Co sold out of Accendra Health (ACH) in Q2 2024, closing a stake of 169,000 shares — an estimated $4.68M sold.

Lord, Abbett & Co first reported a position in ACH in Q1 2016 and held it in 2 quarters. The position peaked at $4.68M in Q1 2024. 221 funds tracked by Wall St. Rank hold ACH as of Q2 2024.

  • Lord, Abbett & Co reported no remaining Accendra Health position as of Q2 2024 after selling out during the quarter.
  • Lord, Abbett & Co sold 169,000 Accendra Health shares in Q2 2024, an estimated $4.68M.
  • Lord, Abbett & Co first reported a position in Accendra Health in Q1 2016 and held it in 2 quarters.
  • Lord, Abbett & Co's Accendra Health position peaked at $4.68M in Q1 2024.
  • 221 funds tracked by Wall St. Rank held Accendra Health as of Q2 2024.

Based on Lord, Abbett & Co's 13F filing for Q2 2024, filed 14 Aug 2024.